Home NDC 63833-839 NDC 63833-839 - HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63833-839
Package NDCs from labels 63833-839-01
Manufacturer CSL Behring GmbH
Effective date 2022-02-04
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63833-839-01 HAEGARDAC1 Esterase Inhibitor Subcutaneous (Human) 5.6 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, FOR SOLUTION 6 mL 3000 [iU] in 6mL 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63833-839 HAEGARDA C1 ESTERASE INHIBITOR SUBCUTANEOUS (HUMAN) (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] 8 Unmatched 20220831_e270ad38-adc4-4ed5-88e3-943b93d20a57.zip